NCT05986682 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 30
- units
- Participants
- groups
- description
- Participants with relapsed and/or refractory multiple myeloma who were treated with Belantamab Mafodotin - blmf (BLENREP) in the DCI Oncology outpatient clinics between August 5, 2020 and November 7, 2023.
- id
- BG000
- title
- Multiple Myeloma/Blenrep Participants
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 45
- upper Limit
- 87
- value
- 68
- description
- Age at Treatment Initiation (Baseline)
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 43
- upper Limit
- 85
- value
- 61
- description
- Age at Multiple Myeloma Diagnosis
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- Female
- measurements
- group Id
- BG000
- value
- 14
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 29
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 14
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 14
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 30
- title
- United States
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- title
- Medicare + Commercial
- measurements
- group Id
- BG000
- value
- 3
- title
- Medicare + Military
- measurements
- group Id
- BG000
- value
- 1
- title
- Medicare + Medicaid
- measurements
- group Id
- BG000
- value
- 6
- title
- Commercial Alone
- measurements
- group Id
- BG000
- value
- 1
- title
- Medicaid Alone
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Current Payer type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- title
- At Duke
- measurements
- group Id
- BG000
- value
- 15
- title
- External Location
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Diagnosis Location
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 29
- title
- >= 10% Bone Marrow Plasma Cells
- categories
- measurements
- group Id
- BG000
- value
- 9
- title
- Plasmacytoma (Total)
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Bone Plasmacytoma
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Extramedullary Plasmacytoma
- categories
- measurements
- group Id
- BG000
- value
- 17
- title
- >60% Bone Marrow plasma cells
- categories
- measurements
- group Id
- BG000
- value
- 14
- title
- ≥ 100 serum free light chain (FLC) ratio
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- >1 focal lesion on MRI
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Hypercalcemia
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- Renal Insufficiency
- categories
- measurements
- group Id
- BG000
- value
- 17
- title
- Anemia
- categories
- measurements
- group Id
- BG000
- value
- 21
- title
- ≥ 1 Bone lesion (X-ray, CT, PET)
- description
- Participants may have more than one diagnostic characteristic of MM.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Multiple Myeloma (MM) Diagnostic Characteristics
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- IgG
- measurements
- group Id
- BG000
- value
- 9
- title
- IgA
- measurements
- group Id
- BG000
- value
- 0
- title
- IgD
- measurements
- group Id
- BG000
- value
- 0
- title
- IgE
- measurements
- group Id
- BG000
- value
- 0
- title
- IgM
- measurements
- group Id
- BG000
- value
- 0
- title
- Light Chain Only
- measurements
- group Id
- BG000
- value
- 5
- title
- Non-secretory
- description
- Subtype of MM by Immunoglobulin - as determined at Diagnosis
- param Type
- COUNT_OF_PARTICIPANTS
- title
- MM Subtype - Immunoglobulin (Ig)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- title
- Kappa
- measurements
- group Id
- BG000
- value
- 12
- title
- Lambda
- description
- Subtype of MM by involved serum free light chain - as determined at Diagnosis
- param Type
- COUNT_OF_PARTICIPANTS
- title
- MM Subtype - Involved Serum Free Light Chain
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- R-ISS I
- measurements
- group Id
- BG000
- value
- 5
- title
- R-ISS II
- measurements
- group Id
- BG000
- value
- 23
- title
- Unknown
- description
- The Revised International Staging System (R-ISS) is a prognostic staging system used to stratify patients with MM based on genetic risk as assessed by fluorescence in-situ hybridization (FISH) and routinely used lab values. The R-ISS system consists of stage I: serum beta2-microglobulin \< 3.5 milligram per liter (mg/L), albumin \>= 3.5 gram per deciliter (g/dL), standard-risk chromosomal abnormalities (CA) by FISH and normal lactate dehydrogenase level (LDH); stage II: neither R-ISS stage I nor stage III; and stage III: beta2-microglobulin \>= 5.5mg/L and either high-risk CA by FISH or high LDH.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- R-ISS Score
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 30
- units
- Participants
- groups
- description
- Participants with relapsed and/or refractory multiple myeloma who were treated with Belantamab Mafodotin - blmf (BLENREP) in the DCI Oncology outpatient clinics between August 5, 2020 and November 7, 2023.
- id
- BG000
- title
- Multiple Myeloma/Blenrep Participants
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 45
- upper Limit
- 87
- value
- 68
- description
- Age at Treatment Initiation (Baseline)
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 43
- upper Limit
- 85
- value
- 61
- description
- Age at Multiple Myeloma Diagnosis
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- Female
- measurements
- group Id
- BG000
- value
- 14
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 29
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 14
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 14
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 30
- title
- United States
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- title
- Medicare + Commercial
- measurements
- group Id
- BG000
- value
- 3
- title
- Medicare + Military
- measurements
- group Id
- BG000
- value
- 1
- title
- Medicare + Medicaid
- measurements
- group Id
- BG000
- value
- 6
- title
- Commercial Alone
- measurements
- group Id
- BG000
- value
- 1
- title
- Medicaid Alone
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Current Payer type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- title
- At Duke
- measurements
- group Id
- BG000
- value
- 15
- title
- External Location
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Diagnosis Location
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 29
- title
- >= 10% Bone Marrow Plasma Cells
- categories
- measurements
- group Id
- BG000
- value
- 9
- title
- Plasmacytoma (Total)
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Bone Plasmacytoma
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Extramedullary Plasmacytoma
- categories
- measurements
- group Id
- BG000
- value
- 17
- title
- >60% Bone Marrow plasma cells
- categories
- measurements
- group Id
- BG000
- value
- 14
- title
- ≥ 100 serum free light chain (FLC) ratio
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- >1 focal lesion on MRI
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Hypercalcemia
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- Renal Insufficiency
- categories
- measurements
- group Id
- BG000
- value
- 17
- title
- Anemia
- categories
- measurements
- group Id
- BG000
- value
- 21
- title
- ≥ 1 Bone lesion (X-ray, CT, PET)
- description
- Participants may have more than one diagnostic characteristic of MM.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Multiple Myeloma (MM) Diagnostic Characteristics
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- IgG
- measurements
- group Id
- BG000
- value
- 9
- title
- IgA
- measurements
- group Id
- BG000
- value
- 0
- title
- IgD
- measurements
- group Id
- BG000
- value
- 0
- title
- IgE
- measurements
- group Id
- BG000
- value
- 0
- title
- IgM
- measurements
- group Id
- BG000
- value
- 0
- title
- Light Chain Only
- measurements
- group Id
- BG000
- value
- 5
- title
- Non-secretory
- description
- Subtype of MM by Immunoglobulin - as determined at Diagnosis
- param Type
- COUNT_OF_PARTICIPANTS
- title
- MM Subtype - Immunoglobulin (Ig)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- title
- Kappa
- measurements
- group Id
- BG000
- value
- 12
- title
- Lambda
- description
- Subtype of MM by involved serum free light chain - as determined at Diagnosis
- param Type
- COUNT_OF_PARTICIPANTS
- title
- MM Subtype - Involved Serum Free Light Chain
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- R-ISS I
- measurements
- group Id
- BG000
- value
- 5
- title
- R-ISS II
- measurements
- group Id
- BG000
- value
- 23
- title
- Unknown
- description
- The Revised International Staging System (R-ISS) is a prognostic staging system used to stratify patients with MM based on genetic risk as assessed by fluorescence in-situ hybridization (FISH) and routinely used lab values. The R-ISS system consists of stage I: serum beta2-microglobulin \< 3.5 milligram per liter (mg/L), albumin \>= 3.5 gram per deciliter (g/dL), standard-risk chromosomal abnormalities (CA) by FISH and normal lactate dehydrogenase level (LDH); stage II: neither R-ISS stage I nor stage III; and stage III: beta2-microglobulin \>= 5.5mg/L and either high-risk CA by FISH or high LDH.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- R-ISS Score
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle